The 27th Asia Pacific League of Associations for Rheumatology (APLAR) Congress is a premier international scientific event dedicated to the advancement of rheumatology in the Asia-Pacific region. The congress serves as a critical platform for rheumatologists, researchers, and allied health professionals to exchange cutting-edge clinical data, share breakthrough research findings, and discuss best practices in the diagnosis and management of rheumatic and musculoskeletal diseases (RMDs). It features a comprehensive scientific program encompassing plenary lectures, specialized Local Organizing Committee (LOC) sessions, and Special Interest Group (SIG) meetings, emphasizing cross-disciplinary collaboration and the translation of novel immunological and genetic research into clinical practice.
Learning Objectives
Following participation in this congress, attendees should be able to:
Evaluate the latest therapeutic advancements and treatment strategies for complex autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus (SLE), and spondyloarthritis.
Analyze the safety and efficacy profiles of targeted therapies, such as JAK inhibitors and glucocorticoids, in clinical practice.
Incorporate new insights from genetics, precision medicine, and trans-omics studies into the pathophysiology and management of rheumatic diseases.
Identify and manage systemic complications of rheumatic diseases, including lung complications in connective tissue diseases and reproductive health issues.
Apply advanced pathological and imaging skills to improve diagnostic accuracy in rheumatology.
Target Audience
Rheumatologists, internal medicine physicians, clinical researchers, allied health professionals, and medical trainees involved in the comprehensive care of patients with rheumatic and musculoskeletal diseases.
Best for Rheumatologists, Orthopedic Surgeons, Pediatricians, Pathologists, Pulmonologists, Medical Geneticists, and Radiologists.
Topics
Rheumatoid Arthritis (RA)
Future perspectives of rheumatoid arthritis.
Surgery of rheumatoid foot and ankle.
Surgery of rheumatoid hand and elbow.
State-of-the-Art rheumatoid arthritis.
SIG – Rheumatoid arthritis.
Systemic Lupus Erythematosus (SLE) & Systemic Autoimmune Diseases
New treatment strategies for SLE.
State-of-the-Art SLE.
SLE-comorbidities and less common manifestations.
SLE-Therapeutic advances in SLE.
Breakthrough Therapies and Emerging Challenges in Systemic Autoimmune Diseases.
Breakthrough Genetics and Emerging Challenges in Systemic Autoimmune Diseases.
Pros or cons of glucocorticoid for systemic autoimmune diseases.
Pediatric & Juvenile Rheumatology
Childhood-onset SLE.
Systemic JIA.
SIG – Paediatric.
Spondyloarthritis & Psoriatic Diseases
State-of-the-Art spondyloarthritis.
SIG – SpA.
GRAPPA session.
Connective Tissue Diseases (CTDs) & Related Conditions
SIG – Sjogren.
SIG – Scleroderma.
SIG – Myositis (IIM).
SIG – Vasculitis.
Management of lung complications in CTDs- Moving forward.
Bone, Joint & Crystal-Induced Diseases
SIG – Osteoporosis.
SIG – Osteoarthritis.
SIG – Crystal-induced arthritis Current Trends in Gout Management.
Genetics, Pathophysiology & Precision Medicine
Inborn Errors and Somatic Mosaicism in Adult Autoinflammatory Diseases.
Cutting-edge of Trans-omics Studies on Rheumatic Diseases.
Pathophysiology of Arthritis and Osteoimmunology.
Autoimmunity and Precision Medicine.
SIG – Genetics.
Clinical Practice, Therapeutics, Safety & Diagnostics
Managing safety of JAK inhibitors.
Pathological skills for rheumatologists.
SIG – Imaging-Advances in Imaging in Rheumatology.
SIG – Digital Health and Telemedicine.
Epidemiology, Public Health & Specialized Issues
SIG – Epidemiology.
SIG – Social Commitment & Patient Outreach.
SIG – Womens Health & Reproductive Issues in RMDs.
COPCORD session.
Collaborative & General Sessions
State-of-the-Art Rheumatology from the Young Generation.
Historical Perspectives in Rheumatology.
APLAR – ACR symposium.
APLAR – EULAR symposium.




Reviews
There are no reviews yet.